-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,935.00(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 75909.0
- ISIN : INE0LRU01027
-
Today’s Low
718.00 -
Today’s High
764.40

-
Open
753.90 -
Perv Close
753.90 -
52W Low
487.85 -
52W High
837.25
Key Indicators
-
P/E(TTM)
28.78
-
Mar.Cap (₹Cr.)
6,663.00
-
Div & Yield %
0.41
-
Book Value(₹)
188.33
-
Debt-Equity Ratio
-2.49
-
AGM Date
25-Apr-2025
-
EPS
25.54
-
P/E Ratio
28.78
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
6,663.00
-
RONW (%)
13.08
-
ROCE (%)
16.60
Score Board
-
Equity (₹ in Cr.)
45.32
-
BV (₹)
188.30
-
Sales( ₹ in Cr.)
1,502.13
-
NP (in Cr.)
200.65
-
NP Var(%)
17.0
-
Div%
60.0
-
CPS (₹)
29.40
-
EPS (₹)
22.10
-
Traded Value (₹ in Lakhs)
6,661.19
-
52 Week High
837.25
-
52 Week Low
487.85
-
Price BSE
735.0
-
Price NSE
735.00
-
Market Capital( in Cr.)
6,661.19
-
P/C Ratio
25.00
-
P/E Ratio
33.20
-
Price Vs.BV
22.10
-
25-Apr-2025( 11:27)
Corporate News - Aarti... - Aarti Pharmalabs will hold a...
-
16-Apr-2025( 04:40)
Corporate News - Aarti... - <P>Aarti Pharmalabs annou...
-
06-Feb-2025( 11:08)
Hot Pursuit - Aarti... - Revenue from operations grew 1...
-
06-Feb-2025( 07:28)
Results - Announcements - Aarti... - Net profit of Aarti Pharmalabs...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,502.13 | 1,511.25 | 941.02 | 0.00 | 0.00 | - |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Net Sales | 1,502.13 | 1,511.25 | 941.02 | 0.00 | 0.00 | - |
Other Income | 11.01 | 1.28 | 2.51 | 0.00 | 0.00 | - |
Stock Adjustments | 23.36 | 91.22 | 32.54 | 0.00 | 0.00 | - |
Total Income | 1,536.50 | 1,603.75 | 976.07 | 0.00 | 0.00 | - |
EXPENDITURE : | ||||||
Raw Materials | 775.33 | 909.15 | 484.20 | 0.00 | 0.00 | - |
Power and Fuel Cost | 82.92 | 74.22 | 43.43 | 0.00 | 0.00 | - |
Employee Cost | 120.15 | 113.92 | 79.98 | 0.00 | 0.00 | - |
Other Manufacturing Expenses | 100.94 | 91.11 | 164.69 | 0.00 | 0.00 | - |
Selling and Administration Expenses | 76.34 | 82.93 | 21.46 | 0.00 | 0.02 | - |
Miscellaneous Expenses | 23.65 | 22.80 | 0.01 | 0.00 | 0.00 | - |
Employee Benefit Expenses | 120.15 | 113.92 | 79.98 | 0.00 | 0.00 | - |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Total Expenses | 1,179.33 | 1,294.14 | 793.78 | 0.00 | 0.02 | - |
Operating Profit | 357.16 | 309.62 | 182.30 | 0.00 | -0.02 | - |
Interest | 16.63 | 20.49 | 11.34 | 0.00 | 0.00 | - |
Gross Profit | 340.53 | 289.13 | 170.96 | 0.00 | -0.02 | - |
Depreciation | 66.01 | 55.77 | 37.23 | 0.00 | 0.00 | - |
Profit Before Tax | 274.52 | 233.36 | 133.73 | 0.00 | -0.02 | - |
Current Tax | 46.06 | 52.13 | 22.50 | 0.00 | 0.00 | - |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Deferred Tax | 27.82 | 9.50 | 4.50 | 0.00 | 0.00 | - |
Reported Net Profit | 200.65 | 171.73 | 106.73 | 0.00 | -0.02 | - |
Extraordinary Items | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | - |
Adjusted Net Profit | 200.65 | 171.73 | 106.70 | 0.00 | -0.02 | - |
Adjustment below Net Profit | 0.00 | 0.00 | 599.24 | 0.00 | 0.00 | - |
P & L Balance brought forward | 859.55 | 705.95 | -0.02 | -0.02 | 0.00 | - |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Appropriations | 18.13 | 18.13 | 0.00 | 0.00 | 0.00 | - |
P & L Balance carried down | 1,042.07 | 859.55 | 705.95 | -0.02 | -0.02 | - |
Dividend | 18.13 | 18.13 | 0.00 | 0.00 | 0.00 | - |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Equity Dividend (%) | 60.00 | 40.00 | 0.00 | 0.00 | 0.00 | - |
Dividend Per Share(Rs) | 3.00 | 2.00 | 0.00 | 0.00 | 0.00 | - |
Earnings Per Share-Unit Curr | 22.14 | 18.95 | 4,269.05 | -0.18 | -0.75 | - |
Earnings Per Share(Adj)-Unit Curr | 22.14 | 18.95 | - | - | - | - |
Book Value | 178.92 | 158.74 | 49,558.52 | 9.07 | 9.25 | - |
Book Value(Adj)-Unit Curr | 178.92 | 158.74 | - | - | - | - |